Did boundary violations sink MDMA-assisted therapy, or was there something more? In part II of our series, we look at what else went wrong.

Did boundary violations sink MDMA assisted psychotherapy? We explore the reasons behind the FDA panel’s rejection of this psychedelic therapy.

Clinicians who have lived with mental illness share how it impaired them - and strengthened them - on the job.

As we delved into Carl Jung's archetype of the wounded healer last Monday, it reminded us of something we learned about the serotonin transporter gene. Has modern genetics discovered a pathway to the archetype? You be the judge in this throwback to a 2021 episode. 

Clinicians who have lived with mental illness show us how to build a deeper empathy from our past wounds, starting with Carl Jung.

Clinicians who live with mental illness share the do’s and don’t’s of self-disclosure.

14 clinicians with mental illness share how they ask patients about mania, depression, psychosis, OCD, panic disorder, addiction, trauma, and suicide.

What steps should clinicians take if psychopharmacologic treatments and school behavioral strategies are insufficient for managing a child with ADHD? We've all been there. ADHD, attention deficit hyperactivity disorder, of course, affects millions of children and adolescents worldwide and can significantly impact focus, impulses, and engagement with friends.

Parents and caregivers need to understand the different kinds of medications and therapies that are available to help manage ADHD. In this podcast, Mara and I will explore the various treatment options for ADHD in children and discuss how to navigate the process of selecting more effective treatments.

In today's episode, Dr. Brian Hurley provides expert insights into the current state of stimulant use disorder, its implications across different regions, and available treatment options.